The tech appears impressive but an 8 person clinical trial is not an overly large metric to base the success on.
A clinic research paper was published last year by the European Society of Cardiologists titled
"European experience with a first totally leadless cardiac resynchronization therapy pacemaker system" (google is your friend) which goes into greater detail about the tech and the actual trial and has some interesting comments in the paragraph at the end titled "Limitations" if anyone is up for some light reading
- Forums
- IPOs
- EBR systems
The tech appears impressive but an 8 person clinical trial is...
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online